Safety Alert for Freshlook Colorblends (phemfilcon A) Contact Lenses

According to Food and Drug Administration Philippines, this safety alert involved a device in Philippines that was produced by N/A.

What is this?

Alerts provide important information and recommendations about products. Even though an alert has been issued, it does not necessarily mean a product is considered to be unsafe. Safety Alerts, addressed to health workers and users, may include recalls. They can be written by manufacturers, but also by health officials.

Learn more about the data here
  • Type of Event
    Safety alert
  • Event Number
    2019-006
  • Event Country
  • Event Source
    FDAP
  • Event Source URL
  • Notes / Alerts
    Data from the Philippines is current through 2019. All of the data comes from the Food and Drug Administration Philippines, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Philippines.
  • Extra notes in the data
  • Reason
    The food and drug administration (fda) advises the public against the purchase and use of the counterfeit medical device product freshlook colorblends (phemfilcon a) contact lenses. fda, in coordination with the market authorization holder (mah), alcon laboratories (phils.), inc., has verified that the aforementioned medical device product is a counterfeit. according to alcon laboratories (phils.), inc., the ciba vision corporation – illinois, usa already ceased production of freshlook family soft contact lenses, which includes freshlook (phemfilcon a) colorblends contact lenses (dvr-4802) in november 2013 and last lots produced bear an expiration dating october 2018. accordingly, since this counterfeit medical device has not gone through evaluation and testing process of the fda, the agency cannot guarantee its quality and safety. the consumption of such violative product may pose potential health hazards to the consuming public. in light of the above, the public is advised not to purchase and use the aforementioned violative product and to be vigilant against medical device that might not be duly registered with fda. always check if a medical device has been registered with the fda before purchasing it by making use of the embedded search feature of the fda website accessible at www.Fda.Gov.Ph. all concerned establishments and/or entities are warned not to distribute the above-identified violative medical device product, otherwise, regulatory actions and sanctions shall be strictly pursued. all local government units (lgus) and law enforcement agencies (leas) are requested to ensure that this product is not sold or made available in their localities or areas of jurisdiction. for more information and inquiries, please e-mail us at this email address is being protected from spambots. you need javascript enabled to view it. , or call us at the center for device regulation, radiation health and research (cdrrhr) hotline (02) 857-1900 local 8301.   attachments: fda advisory no. 2019-006.Pdf.

Device

Manufacturer

N/A
  • Source
    FDAP